Table 2.

Effect of M channel enhancers on the M current amplitude (in nanoamperes) after phosphatidylinositol 4,5-bisphosphate (PIP₂) depletion

	Control		Enhancer		Rapamycin		Rapamycin + enhancer
Treatment	0 mV	−60 mV	0 mV	−60 mV	0 mV	−60 mV	0 mV	−60 mV
Rtg, n = 9	0.56 ± 0.15	0.08 ± 0.01	0.92 ± 0.22	0.18 ± 0.04	0.22 ± 0.08	0.03 ± 0.01	0.50 ± 0.17	0.14 ±0.06
Flu, n = 9	0.78 ±0.13	0.13 ± 0.06	1.10 ± 0.15	0.19 ± 0.08	0.30 ± 0.07	0.08 ± 0.04	0.45 ± 0.09	0.12 ± 0.04
ZnPth, n = 12	0.77 ± 0.12	0.13 ± 0.04	1.54 ± 0.23	0.35 ± 0.07	0.35 ± 0.08	0.11 ± 0.04	1.18 ± 0.16	0.37 ± 0.06
H2O2, n = 8	1.17 ± 0.13	0.10 ± 0.02	2.02 ± 0.34	0.25 ± 0.07	0.48 ± .012	0.07 ± 0.02	1.58 ± 0.20	0.20 ± 0.05

Statistical comparison of data is given in Figs 3 and 5.